Welcome to our dedicated page for Blue Foundry Ban SEC filings (Ticker: BLFY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing a bank’s SEC paperwork can feel like learning a new language—especially when Blue Foundry Bancorp’s 10-K dives deep into net-interest margins, credit-loss allowances, and deposit mix shifts. If you have ever wondered how to spot branch-level profitability trends or track rising interest-rate exposure, this SEC filings hub solves that problem.
Our platform delivers AI-powered summaries that turn dense disclosures into plain-English insights. Jump straight from a Blue Foundry Bancorp annual report 10-K simplified section to loan-portfolio tables, or open a Blue Foundry Bancorp quarterly earnings report 10-Q filing with instant margin analysis. Need real-time alerts? Blue Foundry Bancorp Form 4 insider transactions real-time are streamed within minutes, so you never miss executive stock moves. You will also find:
- Blue Foundry Bancorp insider trading Form 4 transactions with historical context
- Blue Foundry Bancorp proxy statement executive compensation breakdowns
- Blue Foundry Bancorp 8-K material events explained in concise briefs
Whether you are comparing quarter-over-quarter deposit cost trends or monitoring liquidity ratios, real-time filing updates and expert commentary keep every document current. The result: understanding Blue Foundry Bancorp SEC documents with AI means fewer hours scrolling and more hours deciding. Use the platform to:
- Identify interest-rate sensitivity in seconds
- Monitor Blue Foundry Bancorp executive stock transactions Form 4 before earnings
- Access Blue Foundry Bancorp earnings report filing analysis without accounting jargon
From the first mortgage note in an S-1 to the latest Blue Foundry Bancorp SEC filings explained simply, every disclosure is here, searchable, and readable—so you can act with confidence.
Blue Foundry Bancorp (BLFY) filed a Form 8-K dated June 23, 2025 announcing its sixth share-repurchase program.
The Board has authorized the Company to buy back up to 1,082,533 common shares, representing approximately 5 % of shares outstanding. The program began on June 20, 2025 and carries no stated expiration.
Repurchases may be executed on the open market, through private or block transactions, or via Rule 10b5-1 trading plans. Management retains full discretion to suspend, modify or terminate the program at any time, citing factors such as market conditions, pricing, liquidity and alternative capital uses.
No financial statements were required, and the Company did not commit to repurchasing a specific number of shares within a set timeframe. Exhibit 99.1 contains the corresponding press release, which is incorporated by reference.
Form 4 Overview: Maravai LifeSciences Holdings, Inc. (MRVI) disclosed that director John A. DeFord acquired 89,139 shares of Class A common stock on 16 June 2025.
Transaction details: The shares were granted as restricted stock units (RSUs) under the company’s 2020 Omnibus Incentive Plan at an assigned value of $2.16 per share. These RSUs will vest in full on the earlier of (i) one year from the grant date or (ii) the date of the 2026 annual shareholder meeting.
Post-transaction ownership: Following the award, DeFord’s beneficial ownership rises to 159,185 shares, all held directly.
Implications: A director increasing his stake—albeit via equity compensation—tends to align management and shareholder interests and can be interpreted as a vote of confidence in MRVI’s long-term prospects. Because the grant stems from an incentive plan rather than an open-market purchase, any cash outlay by the insider is not indicated in the filing.